Abstract:BACKGROUND:Tumor heterogeneity may lead to false negative test results for tissue biopsy-based companion diagnostic tests. Real-time polymerase chain reaction (PCR) and digital PCR assays are used to detect rare alleles in cell-free circulating DNA for liquid biopsies; however, those tests lack strong sensitivity at low allele frequencies. We show here a novel real-time digital PCR instrument that utilizes cycle-based amplification curves to further improve the sensitivity and quantification accuracy of digital PCR.METHODS:The novel real-time digital PCR instrument was compared to an endpoint digital PCR system to determine the sensitivity and quantification accuracy of both instruments. Samples were all thermal cycled on the real-time digital PCR instrument but were analyzed on both endpoint and real-time digital PCR instruments to compare the performance without introducing other variables. Contrived samples for epidermal growth factor receptor (EGFR) exon 19 deletion, T790M, and L858R point mutations as well as human epidermal growth factor receptor 2 (HER2) amplification were tested. Different mutant allele frequencies and wildtype to mutant gene copy number ratios were tested for EGFR and HER2, respectively.RESULTS:By removing false positive datapoints using real-time amplification curves, real-time digital PCR improved sensitivity by lowering the baseline for wildtype samples. For EGFR 19del assay, samples with 2 or more fluorescein amidite (FAM) labeled positive wells are determined positive by real-time digital PCR, while a minimum of 5 FAM positive datapoints is needed by endpoint digital PCR. Improved limit of detection for EGFR 19del mutation was also observed. Real-time digital PCR also had better quantification accuracy and sensitivity, resulting in the mutant allele frequencies being closer to the expected values for all EGFR mutations, especially at very low allele frequencies. However, at high allele frequencies or for gene amplification assays, real-time digital PCR is comparable with endpoint digital PCR.CONCLUSIONS:This novel technology with improved sensitivity is important and needed because it addresses current issues with liquid biopsy tests. Due to limited amounts of circulating tumor DNA (ctDNA) obtained for liquid biopsy tests, few copies of mutant alleles are expected. With the lower baseline of real-time digital PCR, false negative test results from tissue biopsy would be more effectively reduced, leading to more patients receiving the targeted therapy they need for better survival.

Ultra-sensitive and Multiplex Digital-Pcr for Quantifying the Mutants in Cell Free DNA by Employing Invasive Reaction As Identifier

A superior strategy for single-cell mutational screening via multiplex-targeted QPCR using the BioMark HD microfluidic platform.

A Self-Priming Digital Polymerase Chain Reaction Chip for Multiplex Genetic Analysis

Recent Advance in Digital PCR

Controlled Rehydration of Dried Reagents for Robust Multiplex Digital PCR

Ultrafast and Highly Specific Detection of One-Base Mutated Cell-Free DNA at a Very Low Abundance

Combination of a modified block PCR and endonuclease IV-based signal amplification system for ultra-sensitive detection of low-abundance point mutations.

A Direct and Multiplex Digital PCR Chip for EGFR Mutation

All‐In‐One OsciDrop Digital PCR System for Automated and Highly Multiplexed Molecular Diagnostics

T-shaped Probe System with Low Detection Limits, Versatility and Low Cost for Multiple Mutation Detection

Real-time Digital Polymerase Chain Reaction (PCR) As a Novel Technology Improves Limit of Detection for Rare Allele Assays.

Emerging digital PCR technology in precision medicine

Multiplexed Detection of Mutant Circulating Tumor DNA Using Peptide Nucleic Acid Clamping Asymmetric Polymerase Chain Reaction and Liquidchip.

Multiplex Digital PCR with Digital Melting Curve Analysis on a Self-Partitioning SlipChip.

Novel 100 000 Hexagonal Microchamber Chip Digital PCR for Absolute Quantification of Gene Mutations in Lung Cancer

Ultrasensitive single-nucleotide polymorphism detection using target-recycled ligation, strand displacement and enzymatic amplification.

Single-molecule detection of cancer mutations using a novel PCR-LDR-qPCR assay

Highly Sensitive and Specific Real-Time PCR by Employing Serial Invasive Reaction As a Sequence Identifier for Quantifying EGFR Mutation Abundance in Cfdna

Multiple single cell screening and DNA MDA amplification chip for oncogenic mutation profiling.

Utpcr: A Strategy for the Highly Specific and Absolutely Quantitative Detection of Single Molecules Within Only Minutes.

A Digital PCR Method Based on Highly Specific Taq for Detecting Gene Editing and Mutations